Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:4768728.
doi: 10.1155/2016/4768728. Epub 2016 May 8.

Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program

Affiliations

Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program

Lawrence Paszat et al. Can J Gastroenterol Hepatol. 2016.

Abstract

Background. This work examines the occurrence of interval colorectal cancers (CRCs) in the Ontario ColonCancerCheck (CCC) program. We define interval CRC as CRC diagnosed within 2 years following normal guaiac fecal occult blood testing (gFOBT). Methods. Persons aged 50-74 who completed a baseline CCC gFOBT kit in 2008 and 2009, without a prior history of CRC, or recent colonoscopy, flexible sigmoidoscopy, or gFOBT, were identified. Rates of CRC following positive and normal results at baseline and subsequent gFOBT screens were computed and overall survival was compared between those following positive and normal results. Results. Interval CRC was diagnosed within 24 months following the baseline screen among 0.16% of normals and following the subsequent screen among 0.18% of normals. Interval cancers comprised 38.70% of CRC following the baseline screen and 50.86% following the subsequent screen. Adjusting for age and sex, the hazard ratio (HR) for death following interval cancer compared to CRC following positive result was 1.65 (1.32, 2.05) following the first screen and 1.71 (1.00, 2.91) following the second screen. Conclusion. Interval CRCs following gFOBT screening comprise a significant proportion of CRC diagnosed within 2 years after gFOBT testing and are associated with a higher risk of death.

PubMed Disclaimer

References

    1. Hewitson P., Glasziou P., Watson E., Towler B., Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. The American Journal of Gastroenterology. 2008;103(6):1541–1549. doi: 10.1111/j.1572-0241.2008.01875.x. - DOI - PubMed
    1. Moss S. M., Hardcastle J. D., Coleman D. A., Robinson M. H. E., Rodrigues V. C. Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test. International Journal of Epidemiology. 1999;28(3):386–390. doi: 10.1093/ije/28.3.386. - DOI - PubMed
    1. Steele R. J. C., McClements P., Watling C., et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut. 2012;61(4):576–581. doi: 10.1136/gutjnl-2011-300535. - DOI - PubMed
    1. Gill M. D., Bramble M. G., Rees C. J., Lee T. J. W., Bradburn D. M., Mills S. J. Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme. British Journal of Cancer. 2012;107(3):417–421. doi: 10.1038/bjc.2012.305. - DOI - PMC - PubMed
    1. Segnan N., Patnick J., von Karsa L., editors. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. European Union; 2010. - PubMed

LinkOut - more resources